PG
ABBV icon

PEAK6 Group’s AbbVie ABBV Stock Holding History

PEAK6 Group’s Portfolio ABBV Stock Details ABBV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q2 		$14.6M Sell
157,800
-243,500
-61% -$23.8M 0.06% 308
2018
Q1 		$38M Buy
401,300
+243,400
+154% +$26.7M 0.17% 91
2017
Q4 		$15.3M Buy
157,900
+39,100
+33% +$3.68M 0.07% 309
2017
Q3 		$10.6M Sell
118,800
-104,500
-47% -$7.95M 0.05% 395
2017
Q2 		$16.2M Sell
223,300
-94,500
-30% -$6.35M 0.09% 216
2017
Q1 		$20.7M Sell
317,800
-208,100
-40% -$13.1M 0.17% 117
2016
Q4 		$32.9M Sell
525,900
-103,600
-16% -$6.32M 0.23% 54
2016
Q3 		$39.7M Sell
629,500
-21,900
-3% -$1.42M 0.3% 35
2016
Q2 		$40.3M Buy
651,400
+173,900
+36% +$10.6M 0.31% 28
2016
Q1 		$27.3M Sell
477,500
-103,000
-18% -$5.74M 0.22% 71
2015
Q4 		$34.4M Sell
580,500
-150,200
-21% -$8.65M 0.23% 52
2015
Q3 		$39.8M Sell
730,700
-185,800
-20% -$12.1M 0.21% 75
2015
Q2 		$61.6M Buy
916,500
+441,300
+93% +$28.8M 0.37% 18
2015
Q1 		$27.8M Buy
475,200
+95,600
+25% +$5.78M 0.21% 65
2014
Q4 		$24.8M Buy
379,600
+331,000
+681% +$20.9M 0.19% 94
2014
Q3 		$2.81M Sell
48,600
-22,400
-32% -$1.24M 0.02% 986
2014
Q2 		$4.01M Buy
71,000
+49,900
+236% +$2.62M 0.04% 651
2014
Q1 		$1.08M Sell
21,100
-79,800
-79% -$4.03M 0.01% 1795
2013
Q4 		$5.33M Sell
100,900
-163,500
-62% -$8.04M 0.04% 683
2013
Q3 		$5.92M Buy
264,400
+135,600
+105% +$6.01M 0.04% 638
2013
Q2 		$5.33K Buy
+128,800
New +$5.63M 0.02% 714

Other funds holding ABBV

Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return
OAG
Orbis Allan Gray Hamilton, Bermuda $23.7B AUM 65.43% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

PEAK6 Group's ABBV Position: Q2 2018 in Review

PEAK6 Group sold out of AbbVie (ABBV) in Q2 2018, closing a stake of 137,130 shares — an estimated $13.4M sold.

PEAK6 Group first reported a position in ABBV in Q2 2013 and held it in 13 quarters. The position peaked at $21M in Q3 2015. 1,996 funds tracked by Wall St. Rank hold ABBV as of Q2 2018.

  • PEAK6 Group reported no remaining AbbVie position as of Q2 2018 after selling out during the quarter.
  • PEAK6 Group sold 137,130 AbbVie shares in Q2 2018, an estimated $13.4M.
  • PEAK6 Group first reported a position in AbbVie in Q2 2013 and held it in 13 quarters.
  • PEAK6 Group's AbbVie position peaked at $21M in Q3 2015.
  • 1,996 funds tracked by Wall St. Rank held AbbVie as of Q2 2018.

Based on PEAK6 Group's 13F filing for Q2 2018, filed 15 Aug 2018.